Video
The Importance of Diverse Clinical Trials in Cancer
Author(s):
Donna Cryer, CEO and president of the Global Liver Institute, discusses the importance of having diverse clinical trials in cancer care.
Donna Cryer, CEO and president of the Global Liver Institute, discusses the importance of having diverse clinical trials in cancer care.
While patients may not often be aware of clinical trials, it might be the best treatment option for many of them. It is crucial that these patients talk to other patients who were on clinical trials, as well as their health care providers to better understand the process and become more comfortable with them.
Also, it is crucial that minorities and people around the world of different ethnic backgrounds participate in clinical trials so that when a therapy is approved, its efficacy has been proven for a variety of different genetic makeups.
